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Abstract
Background: Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), an immunoglobulin (Ig)-related 
glycoprotein, serves as cellular receptor for a variety of Gram-negative bacterial pathogens associated with the human 
mucosa. In particular, Neisseria gonorrhoeae, N. meningitidis, Moraxella catarrhalis, and Haemophilus influenzae possess 
well-characterized CEACAM1-binding adhesins. CEACAM1 is typically involved in cell-cell attachment, epithelial 
differentiation, neovascularisation and regulation of T-cell proliferation, and is one of the few CEACAM family members 
with homologues in different mammalian lineages. However, it is unknown whether bacterial adhesins of human 
pathogens can recognize CEACAM1 orthologues from other mammals.
Results: Sequence comparisons of the amino-terminal Ig-variable-like domain of CEACAM1 reveal that the highest 
sequence divergence between human, murine, canine and bovine orthologues is found in the β-strands comprising 
the bacteria-binding CC'FG-face of the Ig-fold. Using GFP-tagged, soluble amino-terminal domains of CEACAM1, we 
demonstrate that bacterial pathogens selectively associate with human, but not other mammalian CEACAM1 
orthologues. Whereas full-length human CEACAM1 can mediate internalization of Neisseria gonorrhoeae in transfected 
cells, murine CEACAM1 fails to support bacterial internalization, demonstrating that the sequence divergence of 
CEACAM1 orthologues has functional consequences with regard to bacterial recognition and cellular invasion.
Conclusions: Our results establish the selective interaction of several human-restricted bacterial pathogens with 
human CEACAM1 and suggest that co-evolution of microbial adhesins with their corresponding receptors on 
mammalian cells contributes to the limited host range of these highly adapted infectious agents.
Background
The immunoglobulin (Ig) superfamily contains a large
number of receptors that serve as cell adhesion molecules
(CAMs) mediating homotypic cell-cell-adhesion in mul-
ticellular animals. One group of mammalian IgCAMs is
named according to the carcinoembryonic antigen
(CEA), a tumor marker used in the surveillance of colon
cancer [1]. Interestingly, CEA is only known from pri-
mates, where it is expressed by mucosal epithelial cells.
Similar to CEA, most other CEA-related CAMs
(CEACAMs) are restricted to specific mammalian lin-
eages, and only a few CEACAMs, such as CEACAM1 or
CEACAM16-20, have orthologues in distantly related
mammals [2-4]. Accordingly, sequence comparisons
based on published genome data have provided evidence
that CEACAMs have independently diversified in each
mammalian order [3,5].
In humans, CEACAM1 is the target of several Gram-
negative commensal and pathogenic bacteria that inhabit
the nasopharyngeal, intestinal, or urogenital mucosa. In
particular, Neisseria gonorrhoeae, N. lactamica, N. menin-
gitidis, N. subflava, Haemophilus influenzae, Moraxella
catarrhalis, and Escherichia coli strains have been found
to associate with the protein core or carbohydrate struc-
tures of this glycoprotein [6-11]. These bacterial species
utilize distinct surface proteins (adhesins) to engage
CEACAMs. For example, the neisserial colony opacity
associated (Opa) proteins allow gonococci and meningo-
cocci to bind several CEACAM family members includ-
ing CEACAM1, CEA, and CEACAM6, which are
expressed on the apical surface of mucosal epithelial cells.
Opa proteins are integral outer membrane proteins with
8 transmembrane β-strands and 4 small extracellular
loops, with the central loops participating in CEACAM
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recognition [12]. Opa-like proteins with a similar β-barrel
structure are also found in commensal Neisseria species
and can mediate the association with CEACAM1 [11]. In
addition, several typeable and non-typeable strains of
Haemophilus influenzae, a species that shares the
mucosal habitat and lifestyle of Neisseria, can engage
CEACAM1 via their outer membrane protein P5 [9].
Another inhabitant of the human oro-pharyngeal
mucosa, Moraxella catarrhalis, can bind via the UspA1
surface protein to the N-terminal domain of CEACAMs
[10]. UspA1 belongs to the family of trimeric autotrans-
porter or oligomeric coiled-coil adhesin (Oca) family. The
prototype of the Oca family is the adhesin YadA of
enteropathogenic Yersiniae  that has a lollipop structure
with a head group, an extended coiled-coil stalk region
and a membrane anchor domain [13]. The mature tri-
meric UspA1 with a size of about 250 - 300 kDa protrudes
up to 60 nm from the bacterial surface and is therefore
completely distinct from membrane-embedded neisserial
Opa proteins or the Haemophilus protein P5 [13]. Sur-
prisingly, CEACAM recognition by the Moraxella UspA1
is mediated by a short sequence within the stalk region
requiring a bend conformation of the UspA1 extracellular
domain to accommodate CEACAM1 binding [14].
Moraxella  strains lacking this peptide sequence within
their stalk region fail to bind to CEACAMs [15].
The striking convergent evolution of structurally dis-
tinct adhesive proteins to engage CEACAM1 suggests
that this binding is important during the life cycle of
these bacteria. As all CEACAM-binding bacteria greatly
differ in their pathogenic potential, but share the same
ecological niche, it is highly likely that CEACAM-binding
promotes colonization of the mucosa. Indeed, in vitro
experiments have suggested that CEACAM-binding is
not only a means to firmly attach to the host cell surface,
but also suppresses the detachment of infected epithelial
cells [16]. CEACAM-targeting bacterial adhesins might
therefore represent colonization factors that promote the
ability of bacteria to establish a firm foothold in their eco-
logical niche. Whether this specialization is also a deter-
minant of the host range of these bacterial pathogens is
not known. Though bacterial species expressing
CEACAM-binding adhesive proteins are in most cases
human-specific, and have no other natural host organ-
ism, it has not been experimentally tested whether their
adhesins selectively recognize human CEACAMs or can
also bind to orthologues from other mammalian species.
In the present study, we analysed the binding of
CEACAM1 orthologues from several mammals to bacte-
rial pathogens with distinct adhesive proteins. In particu-
lar, we tested Opa protein-expressing N. gonorrhoeae and
N. meningitidis as well as UspA1-expressing M. catarrha-
lis for their ability to recognize CEACAM1 homologues
of human, murine, canine or bovine origin. Biochemical
binding studies clearly demonstrate that these bacteria
selectively interact with human CEACAM1. Further-
more, analyses of bacterial internalization show that the
observed amino acid changes in the amino-terminal
domain of mammalian CEACAM1 orthologues have
clear-cut functional consequences. Accordingly, our data
not only demonstrate that bacterial adhesins have co-
evolved with the receptor molecules of their mammalian
host, but also support the view that the diversification of
CEACAMs in mammalian lineages is a pathogen-driven
process.
Methods
Amino acid sequence alignment
For the amino acid sequence alignment of the N-terminal
domains of CEACAM1 following sequences were used:
human CEACAM1 (hCEA1, NM_001712), murine
CEACAM1a (mCEA1, BC016891), canine CEACAM1
(cCEA1, NM_001097557.1), bovine CEACAM1 (bCEA1,
AY345129), bovine CEACAM1 isoform b (bCEA1b,
AY487418). The alignment was performed using CLUST-
ALW.
Cell culture and transfection
The human embryonic kidney cell line 293T (293 cells)
was cultured in Dulbecco's modified Eagle's medium
(DMEM) containing 10% calf serum at 37°C in 5% CO2
and subcultured every second to third day. 293T cells
were transfected by calcium-phosphate coprecipitation
using 5 - 8 μg of plasmid DNA for each 10 cm culture
dish.
Bacteria and infection
Opa52-expressing (OpaCEA), non-piliated N. gonorrhoeae
MS11-B2.1 (strain N309), and non-piliated, non-opaque
gonococci MS11-B2.1 (strain N302) were kindly provided
by T.F. Meyer (Max-Planck Institut für Infektionsbiologie,
Berlin, Germany) and were cultured as described previ-
ously [17]. Opa-expressing, non-encapsulated N. menin-
gitidis (SiaD mutant of strain MC58) was obtained from
Matthias Frosch (Institut für Hygiene und Mikrobiologie,
Universität Würzburg, Germany). M. catarrhalis strain
ATCC 25238 was obtained from DSMZ (Braunschweig,
Germany). Both Moraxella and Neisseriae were grown on
GC agar plates (Difco BRL, Paisley, UK) supplemented
with vitamins at 37°C, 5% CO2 and subcultured daily. For
infection, bacteria were suspended in DMEM and the
optical density of the suspension was used to estimate the
number of the microorganisms according to a standard
curve generated for each strain.
Recombinant plasmid constructs
Mammalian expression plasmids encoding GFP-tagged
human CEACAM1-4L (hCEACAM1-4L), humanVoges et al. BMC Microbiology 2010, 10:117
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CEACAM1-4S, and the amino-terminal domain of
human CEACAM1 (hCEA1-N) were described previ-
ously [18,19]. Murine CEACAM1-4S was constructed by
amplifying the full-length cDNA of murine CEACAM1-
4S (clone BF584691; ImaGenes, Berlin, Germany) with
primers mCEACAM1-sense 5'-GAAGTTATCAGTCGA-
CATGGAGCTGGCCTCAGCAC-3' and mCEACAM1-
anti 5'-ATGGTCTAGAAAGCTTCCGCCAGACTTCC
TGG-3'. The amino-terminal domain of murine CEACA
M1 was amplified with primers mCEACAM1-sense and
mCEACAM1-N-anti 5'-ATGGTCTAGAAAGCTTGGG
TGTACATGAAATCGC-3'. The N-terminal domains of
bovine CEACAM1 isoforms a and b as well as canine
CEACAM1 were amplified from full-length cDNA using
primers bovine CEACAM1abN for 5'-GAAGTTAT-
CAGTCGACATGGGGACCCCCTCAG-3', bovine CEA
CAM1aN rev 5'-ATGGGTCTAGAAAGCTTGGGAG-
TATGTGGAGGTGTCCAG-3', bovine CEACAM1bN
rev 5'-ATGGTCTAGAAAGCTTTGGAGTACGTGGA
GGTGTCC-3', canine CEACAM1N for 5'-GAAGTTAT-
CAGTCGACATGGAGCCCCCCTCG-3' and canine CE
ACAM1N rev 5'-ATGGTCTAGAAAGCTTGGGAATA
CTTGGAGCTGTCC-3'. All the resulting PCR fragments
were cloned into pDNR-Dual using the In-Fusion PCR
Cloning Kit (Clontech, Mountain View, CA) and trans-
ferred by Cre-mediated recombination into pLPS-3'EGFP
(Clontech) resulting in GFP fused to the carboxy-termi-
nus of the expressed proteins. Full-length human
CEACAM1-4S and murine CEACAM1-4S were also
transferred from pDNR-Dual into pLPS3'mCerulean
resulting in mCerulean fused to the carboxy-terminus of
the expressed proteins. pLPS3'mCerulean was generated
by replacing the GFP coding sequence in pLPS3'EGFP
with the cDNA encoding mCerulean [20] generously pro-
vided by D.W. Piston (Department of Molecular Physiol-
ogy and Biophysics, Vanderbilt University, Nashville,
Tennessee, USA).
Cell lysis and Western blotting
Cell lysis and Western blotting were performed as
described [17] using a rabbit polyclonal antibody against
His-tagged GFP (produced at the animal core facility;
University of Konstanz) or a monoclonal antibody against
Opa proteins (clone 4B2/C11; generous gift of Marc
Achtman, MPI für Infektionsbiologie, Berlin, Germany).
Secondary antibodies were from Jackson ImmunoRe-
search (West Grove, PA).
Binding studies of the different pathogens
Binding studies of the different pathogens with the solu-
ble N-terminal domains of human, murine, bovine and
canine CEACAM1 were performed as described [19].
Briefly, 4 × 107 bacteria were added to CEACAM1-N-
domain-containing cell culture supernatants in a total
volume of 1 ml and incubated for 30 min. After four
washing steps, the samples were analysed on a LSR II
flow cytometer (BD Bioscience, Heidelberg, Germany) by
gating on the bacteria (based on forward and sideward
scatter) and measuring bacteria-associated GFP fluores-
cence. In each case, 10 000 events per sample were
obtained.
Gentamicin protection assay
Gentamicin protection assays were conducted as
described [17]. Briefly, 5 × 105 293 cells were seeded in
24-well plates coated with 10 μg/ml poly-L-lysine. Cells
were infected with 30 bacteria/cell (MOI 30) for two
hours. Then, the medium was replaced with DMEM con-
taining 50 μg/ml gentamicin. After 45 min of incubation
in gentamicin-containing medium, cells were lysed by the
addition of 1% saponin in PBS for 10 min. Suitable dilu-
tions were plated in triplicates on GC agar to determine
the number of recovered viable bacteria.
Flow cytometry invasion assay
Bacterial uptake by transfected 293 cells was analysed by
flow cytometry as described [21]. Prior to infection, bac-
teria were labelled with 0.2 μg/ml 5-(6)-carboxyfluores-
cein-succinylester (fluorescein; Invitrogen-Molecular
Probes, Karlsruhe, Germany) in PBS at 37°C for 30 min.
Cells were infected with labelled bacteria at an MOI of 30
for 2 h. After infection, cells were washed with PBS and
the samples were analysed on a LSR II flow cytometer
(BD Bioscience) by gating on the cells based on forward
and sideward scatter. Cell-associated fluorescein fluores-
cence was measured in the presence of 2 mg/ml trypan
blue to quench fluorescence of extracellular bacteria and
to selectively detect the fluorescence derived from intrac-
ellular bacteria. The percentage of fluorescein-positive
cells was multiplied by the mean fluorescence intensity of
the sample to obtain an estimate of the total number of
internalized bacteria (uptake index). In each sample
10,000 cells were counted.
Immunofluorescence staining
293 cells transfected with the indicated constructs were
seeded onto poly-L-lysine- and fibronectin-coated (10
μg/ml and 4 μg/ml, respectively, in PBS) coverslips in 24-
well plates. Cells were infected for 2 h with 5-(and-6)-car-
boxytetramethylrhodamine-succinimidyl- and biotin-
labelled OpaCEA-expressing N. gonorrhoeae at an MOI of
20 essentially as described [22]. To discriminate between
extracellular and intracellular bacteria, infected samples
were fixed with 4% paraformaldehyde in PBS and washed
three times with PBS, prior to incubation in blocking buf-
fer (PBS, 10% FCS) for 15 min. Extracellular bacteria were
stained with AlexaFluor647-streptavidin (Invitrogen,
Karlsruhe, Germany) diluted 1:100 in blocking buffer forVoges et al. BMC Microbiology 2010, 10:117
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1 h. Following three washes, samples were embedded in
mounting medium (Dako, Glastrup, DK).
Samples were viewed with a TCS SP5 laser scanning
confocal microscope (Leica Microsystems, Wetzlar, Ger-
many) using a 63×, 1.3 NA Plan Neofluar oil-immersion
objective. Fluorescence signals of triple-labelled speci-
m e n s  w e r e  s e r i a l l y  r e c o r d e d  t o  a v o i d  b l e e d - t h r o u g h .
Images were digitally processed with NIH ImageJ and
merged to yield pseudo-coloured pictures.
Results
Mammalian CEACAM1 orthologues show conserved as well 
as divergent regions in their amino-terminal domains
The amino-terminal domain of CEACAM1 is a target for
bacterial pathogens [7,8,10,23,24]. In particular, the non-
glycosylated CC'C"FG-face of the immunoglobulin fold is
the binding interface recognized by microorganisms [25].
T o  a n a l y s e  i f  t h i s  p o t e n t i a l  e v o l u t i o n a r y  p r e s s u r e  b y
pathogens is reflected in sequence variation within this
domain, we aligned and compared the published
sequences of the amino-terminal immunoglobulin vari-
able (Igv)-like domain of human, murine, bovine and
canine CEACAM1 (Fig 1A). Indeed, sequence differences
between the mammalian species are most prominent in
β-strands forming the CC'C"FG-face, whereas the glyco-
sylated AA'BDE-face of the immunoglobulin-fold has a
higher amino acid sequence identity (Fig. 1B). To test if
these sequence differences result in an altered functional-
ity with regard to pathogen binding, we generated several
constructs that allowed us to test the association of
CEACAM amino-terminal Igv-like domains with various
pathogens and to analyse their ability to mediate bacterial
internalization by mammalian cells (Fig. 1C). Accord-
ingly, we expressed Igv-like amino-terminal domains
derived from human, bovine, murine, or canine
CEACAM1 as secreted GFP fusion proteins in human
293 cells, a cell line that does not express any CEACAM
family members endogenously (Fig. 1D). Importantly,
GFP-tagged fusion proteins were found in cell culture
supernatants of transfected cells and were expressed at
similar levels as detected by Western blotting with GFP
antibodies (Fig. 1D).
Binding of Neisseria gonorrhoeae to the amino-terminal 
domain of CEACAM1 is human specific
The soluble GFP-tagged amino-terminal domains of
CEACAM1 orthologues were incubated with isogenic
strains of the human pathogen N. gonorrhoeae. The bac-
terial strains used either expressed a specific Opa protein,
which is known to bind human CEACAM1 and other
human CEACAMs (Ngo OpaCEA), or they did not express
any Opa protein (Ngo Opa-). Opa expression by the
gonococci was confirmed by Western blotting with a
monoclonal antibody against neisserial Opa proteins (Fig.
2A). Following incubation with the amino-terminal
CEACAM1 domains from different mammalian species,
the samples were washed, and the bacteria-associated flu-
orescence was measured by flow cytometry. Clearly, the
non-opaque bacteria (Ngo Opa-) did not reveal a positive
signal in the GFP channel for any tested protein, confirm-
ing that Opa proteins are the sole neisserial factor neces-
sary for CEACAM recognition (Fig. 2B). In contrast to
the non-opaque gonococci, the OpaCEA-expressing bacte-
ria clearly associated with the isolated amino-terminal
Igv-like domain of human CEACAM1 (Fig. 2B). Most
importantly, OpaCEA-positive gonococci did not associate
with the Igv-like domains of murine, canine or bovine ori-
gin (Fig. 2B). These results demonstrate that the associa-
tion of Neisseria gonorrhoeae with CEACAM1 is limited
to the human orthologue of this protein and suggests that
CEACAM1 recognition is species-specific.
Binding of Moraxella catarrhalis and Neisseria meningitidis 
to the amino-terminal domain of CEACAM1 is species-
specific
To extend these findings to other pathogens known to
engage the amino-terminal domain of CEACAM1 we
employed N. meningitidis MC58, a serogroup B strain,
and M. catarrhalis ATCC 25238 in CEACAM binding
assays. Accordingly, the bacteria were incubated with
supernatants containing GFP-tagged amino-terminal
Igv-like domains of distinct mammalian CEACAM1
orthologues, and after washing, the bacteria were ana-
lyzed by flow cytometry for associated GFP-fluorescence.
Similar to what we had observed with N. gonorrhoeae,
both bacterial species did not associate with the amino-
terminal Igv-like domains of bovine, murine, or canine
origin (Fig. 3). In contrast, the human CEACAM1 N-ter-
minal domain was strongly associated with both, N. men-
ingitidis as well as M. catarrhalis (Fig. 3). These results
demonstrate that several Gram-negative human patho-
gens selectively recognize the amino-terminal Igv-like
domain of human CEACAM1 and do not bind to the
same region of orthologues proteins from various mam-
mals.
Human, but not murine CEACAM1 mediates internalization 
of Neisseria gonorrhoeae
As the major isoforms of CEACAM1 contain 4 extracel-
lular Ig domains, we wondered whether other determi-
nants outside of the amino-terminal Igv-like domain
might influence the association with microorganisms
across species boundaries. Therefore, full length murine
CEACAM1-4S (encompassing four extracellular domains
and the short (S) cytoplasmic domain) or human
CEACAM1-4S as well as human CEACAM1-4L were
expressed in 293 cells. GFP- or Cerulean-tagged human
CEACAM1-4L and CEACAM1-4S, as well as murineVoges et al. BMC Microbiology 2010, 10:117
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CEACAM1-4S were expressed at comparable levels as
shown by Western blotting with a polyclonal antibody
against GFP, which recognizes also Cerulean (Fig. 4A).
CEACAM engagement by OpaCEA-expressing N. gonor-
rhoeae was evaluated through functional analysis of bac-
terial uptake by the transfected cells. In a first set of
experiments, we used an antibiotic protection assay that
is based on recovery of viable intracellular bacteria after
treatment of the infected cells with gentamicin, an antibi-
otic that kills extracellular bacteria. In the case of non-
opaque gonococci, only very low numbers of bacteria
were recovered from murine or human CEACAM1-4S
expressing cells similar to the numbers isolated from con-
trol transfected cells (Fig. 4B). In contrast, upon infection
with OpaCEA-expressing N. gonorrhoeae, 50 - 100 times
more bacteria were recovered from cells expressing
human CEACAM1 (Fig. 4B). Similar to what has been
observed before [18], both the short and the long isoform
Figure 1 Amino acid sequence alignment and expression of soluble CEACAM1 proteins of different mammals. (A) Amino acid sequence 
alignment of the N-terminal domains of human, murine, bovine and canine CEACAM1 proteins. The following sequences were used: human 
CEACAM1 (hCEA1, NM_001712), murine CEACAM1a (mCEA1, BC016891), canine CEACAM1 (cCEA1, NM_001097557.1), bovine CEACAM1 (bCEA1, 
AY345129), bovine CEACAM1 isoform b (bCEA1b, AY487418). Amino acids identical to the human CEACAM1 sequence are indicated by dots. The char-
acteristic beta-strands of the Ig variable-like domain are marked by blue lines and letters above the human sequence. (B) Amino acid identity between 
different mammalian CEACAM1 orthologues. Percent identity compared to the human sequence is given for amino acid residues comprising the beta 
strands of either the AA'BDE-face or the CC'C"FG-face of the immunoglobulin fold. (C) Schematic illustration of the proteins used in this study. Human 
CEACAM1-4L isoform containing a long cytoplasmic domain (hCEA1-4L), the human CEACAM1 isoform containing a short cytoplasmic domain 
(hCEA1-4S), and the corresponding murine isoform (mCEA1-4S) were expressed as GFP or cerulean fusion proteins. Amino-terminal Igv-like domains 
of CEACAM1 from human (hCEA1), mouse (mCEA1), dog (cCEA1), or cattle (isoform a, bCEA1a; isoform b, bCEA1b) were expressed in human cells as 
soluble GFP-fusion proteins.Voges et al. BMC Microbiology 2010, 10:117
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Figure 2 OpaCEA protein expressing Neisseria gonorrhoeae selectively binds to human CEACAM1. (A) Neisseria gonorrhoeae MS11 strains lack-
ing Opa protein expression (Ngo Opa-) or expressing a CEACAM-binding Opa protein (Ngo OpaCEA) were lysed and the Opa protein expression was 
determined by Western blotting with a monoclonal anti-Opa antibody (clone 4B12/C11). (B) Expression of the soluble GFP-fusion proteins of 
CEACAM1 Igv-like domains was determined by Western blotting of culture supernatants with polyclonal anti-GFP antibody. Culture supernatants 
from cells transfected with a vector encoding cytoplasmically expressed GFP served as control. (C) Culture supernatants containing soluble GFP-
tagged amino-terminal domains of the indicated mammalian CEACAMs or a control culture supernatant from GFP-transfected cells (neg. control) 
were incubated with OpaCEA protein-expressing N. gonorrhoeae (Ngo OpaCEA) or the non-opaque strain (Ngo Opa-). After washing, bacteria were anal-
ysed by flow cytometry and the bacteria-associated GFP-fluorescence was determined. Only human CEACAM1 (hCEA1) binds to Ngo OpaCEA.
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of human CEACAM1-4 were able to mediate efficient
uptake of the pathogens (Fig. 4B). Importantly, murine
CEACAM1-4S was not able to mediate internalization of
OpaCEA-expressing  N. gonorrhoeae consistent with the
lack of bacterial binding to the Igv-like amino-terminal
domain of murine CEACAM1 (Fig. 4B).
To further confirm that full length murine CEACAM1-
4S does not mediate bacterial internalization, we analy-
sed transfected cells upon infection with fluorescein-
labeled bacteria by an established flow cytometry method
[21]. Addition of trypan blue quenches the fluorescence
emitted by extracellular bacteria, resulting in cell-associ-
ated fluorescence signals derived exclusively from intrac-
ellular bacteria. In line with the results of the antibiotic
protection assay, non-opaque N. gonorrhoeae was not
internalized, whereas OpaCEA-expressing bacteria were
taken up by cells transfected with human CEACAM1-4S
(Fig. 4C). Moreover, cells expressing murine CEACAM1-
4S did not harbor intracellular bacteria, further corrobo-
rating the notion that OpaCEA proteins of N. gonorrhoeae
do not functionally engage CEACAM1 orthologues of
other mammalian species (Fig. 4C).
Microscopic determination of Neisseria gonorrhoeae 
internalization via CEACAM1
To finally demonstrate the selective binding and internal-
ization of OpaCEA-expressing N. gonorrhoeae by human,
but not murine CEACAM1, we analysed infected sam-
ples with confocal fluorescence microscopy. Therefore,
293 cells were transfected with GFP (negative control),
human CEACAM1-4S-GFP, or murine CEACAM1-4S-
GFP. Prior to infection, bacteria were labeled with rhod-
amine and biotin as a pre-requisite to allow the differen-
tial visualization of intracellular and extracellular bacteria
[22]. Cells infected for 2 h with rhodamine/biotin-labeled
bacteria were fixed and the extracellular bacteria were
selectively marked with AlexaFluor647-streptavidin,
which does not have access to intracellular bacteria. In
GFP-expressing cells, bacteria were rarely found associ-
ated with cells (Fig. 5). Moreover, in all cases these
microbes were located outside the GFP-expressing cells
as evidenced by their rhodamine and AlexaFluor647
labeling (Fig. 5, arrowhead). In contrast, cells expressing
human CEACAM1 contained numerous intracellular
bacteria that co-localized with the GFP-tagged receptor
Figure 3 Binding of Neisseria meningitidis and Moraxella catarrhalis to CEACAM1 orthologues. Culture supernatants containing soluble GFP-
tagged amnio-terminal domains of the indicated mammalian CEACAMs or a control culture supernatant from GFP-transfected cells (neg. control) 
were incubated with OpaCEA protein-expressing N. meningitidis or UspA1-expressing M. catarrhalis. After washing, bacteria were analysed by flow cy-
tometry and the bacteria-associated GFP-fluorescence was determined. Only human CEACAM1 (hCEA1) binds to the pathogenic bacteria.
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in intracellular vesicles (Fig. 5, arrow). The absence of the
AlexaFluor647 label clearly confirms the intracellular
localization of these bacteria (Fig. 5, arrow). Similar to the
situation in GFP-transfected cells, 293 cells expressing
murine CEACAM1 showed only very few cell-associated
bacteria and no intracellular bacteria were detected (Fig
5, arrowhead). Though both human as well as murine
CEACAM1-4S-GFP localized on the cell surface, only
human CEACAM1 is recruited to the cell associated bac-
teria and is co-internalized with OpaCEA-expressing
gonococci (Fig 5). Together, these microscopic investiga-
tions provide further evidence, that only the human
CEACAM1 orthologue is a target for the Opa protein
adhesins of N. gonorrhoeae and is able to mediate the
binding and uptake into eukaryotic cells.
Discussion
Members of the CEACAM family serve as receptors for a
variety of Gram-negative bacteria that live on mucosal
surfaces of the human body. In an example of convergent
evolution these microbes have evolved distinct
CEACAM-binding adhesins that seem to promote the
c o loniza t ion o f  t he  m uc osa.  H e r e  we  pr ovi de evide nc e
that CEACAM-binding adhesins from pathogenic Neis-
Figure 4 Internalization of OpaCEA-expressing Neisseria gonorrhoeae is only mediated by human CEACAM1. (A) 293 cells were transfected 
with constructs encoding the indicated human or murine CEACAM1 isoforms fused to GFP or Cerulean. Cells transfected with a GFP-encoding vector 
served as control. After 48 h, cells were lysed and the expression was determined by Western blotting with a polyclonal anti-GFP antibody. (B) Cells 
transfected as in A) were infected with Opa-negative (Ngo Opa-) or OpaCEA-expressing N. gonorrhoeae (Ngo OpaCEA) at an MOI of 30 for 2 h. The num-
ber of viable intracellular bacteria was determined by gentamicin protection assay. Bars represent mean values ± SEM of three independent experi-
ments done in triplicate. For statistical analysis, samples were compared against control transfected cells by one-tailed Mann-Whitney U-test; *, p < 
0.001. (C) 293 cells were transfected with constructs encoding human CEACAM1 isoform containing a short cytoplasmic domain (hCEA1), the corre-
sponding murine isoform (mCEA1) or an empty control vector. Cells were infected with fluorescein-labelled Opa-negative (Ngo Opa-) or OpaCEA-ex-
pressing N. gonorrhoeae (Ngo OpaCEA) at an MOI of 30 for 2 h. The uptake index was determined by flow cytometry as described in Material and 
Methods. Bars represent mean values ± SEM of three independent experiments.
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seriae and Moraxella catarrhalis display a high selectivity
for human CEACAMs and do not associate with ortho-
logues from non-primate mammalian species. Accord-
ingly, the amino acid sequence divergence, that is
particularly high in the CC'C"FG-face of the amino-ter-
minal Igv-like domain of mammalian CEACAM1 ortho-
logues, results in functional differences with regard to
bacterial binding. CEACAM-binding bacterial species,
which specifically colonize and infect humans, only rec-
ognize human CEACAM1 suggesting that the microbial
adhesive proteins have co-evolved with their host recep-
tor.
It has been observed earlier, that CEACAM1 ortho-
logues from different mammalian species display high
sequence diversity [4,5]. Starting from a primordial
CEACAM1-like gene, CEACAMs seem to have under-
gone independent duplication and diversification events
in different mammalian lineages resulting in an expanded
family of closely related surface molecules [2,26]. There-
fore, even within a mammalian order such as the pri-
mates it is difficult to assign orthologues genes except for
CEACAM1 [27]. As several members of the CEACAM
family are exploited by viral and bacterial pathogens, it
has been suggested that the driving force behind the rapid
diversification of CEACAMs in different mammalian lin-
eages might be the selective pressure by pathogens [3,28].
An additional example of CEACAM1 recognition by
pathogens is found in rodents, where the mouse hepatitis
virus strain A59 (MHV-A59), belonging to the coronavi-
rus complex, binds via its spike protein to murine
CEACAM1 [29,30]. Of the two CEACAM1 alleles pres-
ent in the mouse population, MHV-A59 selectively rec-
ognizes CEACAM1a and only marginally binds to the
CEACAM1b allele [31]. Therefore, inbred mouse lines
that carry the CEACAM1a allele are susceptible, whereas
lines carrying the CEACAM1b allele or CEACAM1-defi-
cient mice are resistant to MHV-A59 [32]. However,
despite this selectivity for the murine CEACAM1a allele,
it has been shown that several MHV strains, including
A59 and MHV-2, can utilize human CEACAM1 as well
as CEA to infect eukaryotic cells in vitro [33].
In contrast to this promiscuity of host receptor utiliza-
tion, our results highlight the specificity of bacterial
adhesins for human CEACAMs. Consistent with the
Figure 5 Microscopic verification of N. gonorrhoeae uptake via human CEACAM1. 293 cells were transfected with constructs encoding GFP, hu-
man CEACAM1-4S-GFP, or murine CEACAM1-4S-GFP as indicated. Cells were infected for 2 h with biotin- and rhodamine-labelled non-opaque (Ngo 
Opa-) or OpaCEA-expressing N. gonorrhoeae (Ngo OpaCEA). Infected cells were fixed, but not permeabilized, and samples were stained with 
AlexaFluor647-streptavidin to label extracellular bacteria (Extr. bacteria). Intracellular bacteria (small arrow) are marked by their selective rhodamine 
labelling, whereas extracellular bacteria (arrowheads) are stained with both rhodamine and AlexaFluor647. Bars represent 5 μm.
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strict selectivity of these pathogens for humans as natural
host organisms, they only associate with human
CEACAM1. Accordingly, the bacteria can efficiently
invade only cells that express the human orthologue of
CEACAM1, but not the murine orthologue. It is interest-
ing to note, that additional pathogenicity factors of these
bacteria show a similar exquisite specialisation for human
molecules. For example, the neisserial IgA1 protease [34]
only cleaves human IgA1 molecules, but not IgA mole-
cules from other mammalian species. Similarly, the trans-
ferrin-binding protein, that is critical for iron acquisition
in the human host, can utilize only transferrin from
human sources or from closely related apes such as chim-
panzee [35,36]. Gonococci are also able to escape from
host complement attack by recruiting complement com-
ponent 4b-binding protein (C4bp) [37]. This ability is
again specific for human C4bp and even chimpanzee
C4bp only provides protection from complement for
some, but not all gonococcal strains [38].
Besides immune escape and nutrient acquisition, our
results reveal another area, where these Gram-negative
pathogens employ species-specific pathogenicity factors.
Clearly, adhesion to the mucosal surface epithelium is the
initial step in the colonization by CEACAM-binding bac-
teria, and the possession of adhesive proteins specifically
targeting human CEACAMs might promote this step.
However, at the same time this specialization could con-
tribute to the limited host spectrum not only of patho-
genic Neisseriae, but also of M. catarrhalis and
Haemophilus influenzae.
Conclusions
Recognition of host surface structures is critical for many
bacterial pathogens to establish a first foothold in their
target organism. Whereas a high degree of specificity
might allow intimate binding of the microorganisms to
eukaryotic cells, it might at the same time limit the host
range of the pathogen. Here we reveal a selective interac-
tion between bacteria and the human form of the cell sur-
face receptor CEACAM1 that correlates with the human-
restricted pathogenicity of these microbes. Our analysis
not only points to an ongoing pathogen-host co-evolu-
tion at the level of receptor-adhesin interaction, but fur-
ther strengthens the idea that the OpaCEA  protein-
mediated interaction with human CEACAMs might pro-
vide an access point for preventing or limiting infection.
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